Our Red Blood Cell Membrane and Enzyme Disorders unit studies genetic variants affecting the function and integrity of the human red blood cell membrane and enzymes, as well as other inherited hematological conditions. Currently our unit is focusing on the prevalence and genetic diversity of G6PD deficiency in Indonesia, and other molecular risk factors of hyperbilirubinemia in Indonesia.
In collaboration with the Genetic Counselling Unit of our Institute, our unit is also working on the detection of G6PD deficiency, red blood cell spherocytosis, and other inherited disorders such as Prader-Willi Syndrome (PWS) and/or Angelman Syndrome (AS), and Duchene Muscular Dystrophy (DMD).
- Alida Roswita Harahap
- Ari Winasti Satyagraha
- Arkasha Sadhewa
- Lydia Visita Panggalo
- A double-blind, double-dummy, randomized, parallel group, placebo-controlled, superiority study to evaluate the efficacy and safety of tafenoquine (SB-252263, WR238605) co-administered with dihydroartemisinin-piperaquine (DHA-PQP) for the radical cure of Plasmodium vivax malaria (INSPECTOR)
- Safety, tolerability, immunogenicity and protective efficacy against naturally-transmitted malaria in eastern Indonesia of two Plasmodium falciparum Sporozoite Vaccines, Sanaria® PfSPZ Vaccine and Sanaria® PfSPZ-CVac: a randomized, double-blind, placebo-controlled phase 2 trial in health Indonesian adults
- Serological markers of recent exposure as surrogate biomarkers of hypnozoite carriage: a proof-of-concept study in Indonesian soldiers